--- title: "The Silent Rotation: Inside the Moves of 10 Niche Tech and Defense Players" type: "News" locale: "en" url: "https://longbridge.com/en/news/293316055.md" description: "Institutional capital is quietly rotating into defense tech, biotech, and aerospace. I'm told Twilio and Kratos are preparing strong guidance, while Virgin Galactic races toward a critical Delta-class test flight." datetime: "2026-07-21T09:12:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293316055.md) - [en](https://longbridge.com/en/news/293316055.md) - [zh-HK](https://longbridge.com/zh-HK/news/293316055.md) --- # The Silent Rotation: Inside the Moves of 10 Niche Tech and Defense Players A notable rotation is underway across overlooked pockets of the U.S. market this week. With the broader tech rally taking a breather, institutional capital is quietly trickling into defense tech, cutting-edge biotech, and certain beaten-down speculative plays. I'm told by people familiar with the matter that management teams across these transitional companies are prepping aggressive maneuvers for the second half of 2026, marking the most significant catalyst window for this cohort since late last year. ### Twilio (TWLO.US) Shares of the cloud communications giant have shown recent strength, steadily outperforming the broader market. People familiar with the matter say internal sentiment ahead of their early August Q2 earnings is extremely upbeat. Following a Q1 where total revenue hit **USD 1.41 billion**—a **20%** jump year-over-year—I'm told AI-driven enterprise orders have blown past internal targets this quarter, prompting analysts to quietly adjust their models. ### Kratos Defense & Security Solutions (KTOS.US) As a key Pentagon tech supplier, Kratos has stabilized recently after broad volatility earlier this year. The company is targeting Q2 2026 revenue between **USD 400 million and USD 410 million**. With a backlog nearing the **USD 2 billion** mark, I'm told the firm is aggressively trying to distance itself from rivals in next-generation drone software integration. ### Virgin Galactic (SPCE.US) The commercialization of space travel is hitting a make-or-break moment, and the stock saw a solid uptick this week. According to a recently circulated internal roadmap, the company has locked in **Q3 2026** for the initial glide tests of its Delta-class ships, targeting late-year commercial operations. People familiar with the timeline note this fleet transition is the absolute lifeline for their cash flow over the next two years. ### Upstream Bio (UPB.US) This clinical-stage biotech has been making waves on Wall Street. Its core pipeline drug, Verekitug, is progressing well in severe asthma trials, landing the company on several buy lists. According to individuals close to the clinical team, the long-term efficacy data expected later this year could fundamentally alter its commercial trajectory. ### CRISPR Therapeutics (CRSP.US) The gene-editing leader has faced some recent share price pullbacks. I'm told management is heavily pivoting its strategic focus toward cardiovascular and oncology fields. The company is slated to kick off clinical trials for CTX460 in **mid-2026**. One insider described this as their most critical pipeline expansion since the initial Casgevy approval. ### Also - **Sprott Physical Silver Trust (PSLV.US)**: With precious metal hedging on the rise, this silver trust has seen notable inflows this year, showing resilient recent performance. - **HDFC Bank (HDB.US)**: I'm told the Indian banking behemoth is telegraphing a message of resilient credit growth to Wall Street ahead of its upcoming earnings roadshow. - **Beyond Meat (BYND.US)**: The plant-based meat winter drags on. People familiar with the matter say management faces intensifying pressure in 2026 to slash unprofitable retail channels. - **Julong Holding (JLHL.US)**: The low-profile holding firm has been active in supply chain restructuring lately, attempting to navigate ongoing demand volatility. - **Whitefiber (WYFI.US)**: Industry whispers suggest the company is quietly accelerating its infrastructure network deployments, with quarterly capital expenditures likely to exceed prior forecasts. _This article does not constitute investment advice._ ### Related Stocks - [TWLO.US](https://longbridge.com/en/quote/TWLO.US.md) - [KTOS.US](https://longbridge.com/en/quote/KTOS.US.md) - [SPCE.US](https://longbridge.com/en/quote/SPCE.US.md) - [UPB.US](https://longbridge.com/en/quote/UPB.US.md) - [CRSP.US](https://longbridge.com/en/quote/CRSP.US.md) - [HDB.US](https://longbridge.com/en/quote/HDB.US.md) - [BYND.US](https://longbridge.com/en/quote/BYND.US.md) - [JLHL.US](https://longbridge.com/en/quote/JLHL.US.md) - [WYFI.US](https://longbridge.com/en/quote/WYFI.US.md) ## Related News & Research - [SPCE Options Price In a 7% Earnings Move… But History Says It Could Be Bigger](https://longbridge.com/en/news/294250845.md) - [Twilio (TWLO) Projected to Release Earnings on Thursday](https://longbridge.com/en/news/294321024.md) - [Kratos Defense & Security Solutions (KTOS) Expected to Release Quarterly Earnings on Tuesday](https://longbridge.com/en/news/294090435.md) - [Kratos US Division President Steven S. Fendley sells USD 329,029 of shares](https://longbridge.com/en/news/294263580.md) - [HDFC Bank Concludes Internal Review of MSRDC Deposit Arrangements, Penalizes Senior Executives](https://longbridge.com/en/news/293955566.md)